The effects of hyperlipidaemia on graft and patient outcome in renal transplantation

Domingo Del Castillo1, Josep M Cruzado, Joan Manel Díaz

  • 1Hospital Reina Sofia, Avda. Menendez Pidal 1, 14012 Cordoba, Spain. ddelcastillo@terra.es

Insights

Hypertriglyceridaemia, not high cholesterol, is linked to worse graft survival and cardiovascular mortality in Spanish renal transplant patients. Statins show a protective effect on graft survival.

Area of Science:

  • Nephrology
  • Transplantation Immunology
  • Cardiovascular Medicine

Background:

  • Hyperlipidaemia is a common complication post-renal transplantation.
  • The impact of high cholesterol and triglycerides on cardiovascular disease and graft survival remains debated.
  • Prevalence of hypercholesterolaemia increased in Spanish transplant recipients from 1990-1998, while hypertriglyceridaemia remained stable.

Purpose of the Study:

  • To investigate the differential effects of hypercholesterolaemia and hypertriglyceridaemia on graft survival and cardiovascular mortality in renal transplant recipients.
  • To identify factors associated with hyperlipidaemia in this population.
  • To evaluate the impact of statin therapy on outcomes.

Main Methods:

  • Retrospective analysis of renal transplant recipients in Spain.
  • Comparison of patient characteristics and treatment regimens between groups with and without hypercholesterolaemia and hypertriglyceridaemia.
  • Statistical analysis of risk factors for graft survival and cardiovascular mortality.

Main Results:

  • Hypertriglyceridaemia at 3 months post-transplant was associated with worse graft survival (RR 1.078) and increased cardiovascular mortality (RR 1.265).
  • Patients with hypertriglyceridaemia often received cyclosporine-based immunosuppression and lipid-lowering agents, and had higher creatinine levels.
  • Statin treatment demonstrated a protective effect on graft survival (RR 0.64).

Conclusions:

  • Hypertriglyceridaemia, rather than hypercholesterolaemia, poses a significant risk to graft and patient survival in renal transplant recipients.
  • Management of hypertriglyceridaemia and the use of statins are crucial for improving outcomes in this patient group.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...